本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Jaguar Animal Health, Inc.

8.06
+1.3920.84%
盤後7.95-0.1052-1.31%19:37 EDT
成交量:5.97萬
成交額:46.95萬
市值:543.28萬
市盈率:-0.06
高:8.61
開:6.78
低:6.78
收:6.67
資料載入中...

公司資料

公司名字:
Jaguar Animal Health, Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
49
公司地址:
200 Pine Street,Suite 400,San Francisco,California,United States
郵編:
94104
電話:
傳真:
- -
簡介:
Jaguar Health, Inc.於2013年6月6日在特拉華州成立。該公司是一家商業階段的製藥公司,專註於為患有胃腸道(“GI”)疾病的人和動物開發可持續地從雨林地區的植物中提取的新型專利處方藥。

董事

名稱
職位
James J. Bochnowski
Chairman of the Board
Lisa A. Conte
Chief Executive Officer, President and Director
Anula Jayasuriya
Director
John Micek III
Director
Jonathan B. Siegel
Director

股東

名稱
職位
Lisa A. Conte
Chief Executive Officer, President and Director
Carol R. Lizak
Chief Financial Officer
Ian Wendt
Chief Commercial Officer
Jonathan S. Wolin
Chief of Staff, General Counsel and Chief Compliance Officer
Pravin Chaturvedi
Chief Scientific Officer
Steven R. King
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary